Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic, antiinflammatory drugs? Arguments against. [electronic resource]
Producer: 20061113Description: 413-6 p. digitalISSN:- 0340-6245
- Analgesics -- adverse effects
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Arthritis -- drug therapy
- Aspirin -- therapeutic use
- Cardiovascular Diseases -- chemically induced
- Clopidogrel
- Cyclooxygenase 2 Inhibitors -- adverse effects
- Drug Interactions
- Drug Therapy, Combination
- Gastrointestinal Hemorrhage -- chemically induced
- Humans
- Patient Selection
- Platelet Aggregation Inhibitors -- therapeutic use
- Randomized Controlled Trials as Topic
- Risk Assessment
- Thrombosis -- chemically induced
- Ticlopidine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.